SlideShare una empresa de Scribd logo
1 de 9
Descargar para leer sin conexión
 

  

  

  

  

  

  

  

  

  

  



                 Overview of array-based Copy Number
                 analysis for Cytogenetics
  

                 Topics in Copy Number variation analysis
  

  

  


                                                     October  2009  




©2009  infoQuant,  Ltd                   1                       Doc:  OCPEQS1  
 

  

Contents
  

Overview  .................................................................................................................................................................................  2  

Tools  ........................................................................................................................................................................................  2  

An  array-­‐based  Cytogenetic  Test  ............................................................................................................................................  2  

Using  parental  samples  ...........................................................................................................................................................  4  

Utilizing  accumulated  patient  data  .........................................................................................................................................  4  

Gene  significance  ....................................................................................................................................................................  6  

Conclusion  ...............................................................................................................................................................................  8  

  


Overview
Array  CGH  technique  is  going  through  a  transition  from  being  purely  a  research  tool  to  being  used  in  clinical  Cytogenetic  
tests  on  a  daily  basis.  Such  transition  calls  for  a  new  generation  of  analytical  solutions  capable  of  semi-­‐automated  and  
reliable  copy  number  reporting.  


Tools
oneClickCGH®  is  a  unique  software  package  that  facilitates  automated  analysis  of  array  CGH  data  and  user-­‐friendly  copy  
number  reporting  for  individual  samples.  Cytogenetic  labs  can  use  this  package  to  support  identification  of  clinically  
relevant  copy  number  changes  and  to  build  robust  and  comprehensive  reports.  It  is  capable  of  analyzing  medium-­‐  and  
high-­‐resolution  data  from  various  array  CGH  and  SNP  platforms.  Statistical  algorithms  used  in  this  software  ensure  
reliability  of  aberration  detection,  which  assists  Cytogenetic  users  in  producing  their  final  report  documents.  

CGH  Fusion®  is  a  leading  commercially  validated  package  used  for  analysis  of  array  CGH  data  across  multiple  samples.  It  
is  capable  of  building  copy  number  profiles  for  large  sets  of  samples  within  a  specific  biological  context.  CGH  Fusion  can  
facilitate  constriction  of  libraries  of  copy  number  profiles  characterizing  specific  disorders  or  cohorts  of  healthy  patients  
in  a  simple  user-­‐friendly  manner.  It  can  also  provide  valuable  biological  insights  into  regions  of  frequent  copy  number  
change  by  incorporating  various  gene  annotations  and  known  CNVs.  


An array-based Cytogenetic Test
Usually  analysis  of  test  data  extracted  with  array  CGH  or  SNP  array  starts  with  detection  of  suspected  regions  of  copy  
number  changes.  Several  basic  operations  are  performed  on  raw  data  (depending  on  the  actual  array  platform  used):  
background  subtraction,  normalization,  filtering  of  outlier  replicates  and  actual  detection  of  regions  of  abnormal  log-­‐


©2009  infoQuant,  Ltd                                                                          2                                                                          Doc:  OCPEQS1  
 

  

ratio  values.  All  aforementioned  operations  can  be  performed  automatically  and  almost  no  manual  intervention  is  
needed  at  that  stage.    

  However,  not  all  automatically  detected  chromosomal  aberration  regions  need  to  be  reported  as  relevant  to  the  test.  
Some  of  them  can  be  simply  experimental  defects  and  some  come  from  regions  of  known  genetic  variance,  which  do  not  
contribute  to  the  clinical  condition  under  study.    

Therefore  a  manual  procedure  of  aberration  approval  and  reporting  is  needed.  Such  procedure  usually  is  centered  
around  building  a  final  report  with  manually  approved  copy  number  changes  based  on  references  to  various  knowledge  
databases  (public  or  internal).  Such  aberration  reporting  procedure  can  be  streamlined  with  oneClickCGH,  which  allows  
creation  of  comprehensive  report  documents  in  various  formats  and  facilitates  references  to  publicly  available  
databases  such  as  the  Data  Base  of  Genomic  Variants,  UCSC  Genome  Browser,  OMIM,  Gene  Ontology  database  etc.  

First,  all  detected  copy  number  changes  need  to  be  reviewed  and  gene  and/or  known  CNV  annotations  can  be  used  to  
                                             




                                                                                                            

  After  all  detected  aberrations  have  been  approved  and  necessary  comments  have  been  added,  report  section  of  
oneClickCGH  contains  only  relevant  regions  of  copy  number  change  that  can  be  saved  as  a  report  document  




                                                                                                                                   




©2009  infoQuant,  Ltd                                             3                                                   Doc:  OCPEQS1  
 

  

Using parental samples

ones.    

                                                                                                                          ical.  However,  
                                                  
when  such  data  are  available,  CGH  Fusion can  provide  a  user-­‐friendly  environment  for  identification  and  reporting  
                               

User  can  simply  load  all  available  samples  into  CGH  Fusion,  analyze  them  simultaneously  and  review  them  side  by  side.  
Plot  below  illustrates  this  operation.  




                                                                                                                                                

It  is  easy  to  see  from  this  plot  that  two  out  of  three               mother s)  demonstrate  similar  aberrations,  
which  also  coincide  with  a  region  of  known  CNVs  from  Toronto  DGV  highlighted  with  orange  at  the  top  of  the  plot.  
                                                                                               a  known  CNV  inherited  from  one  of  
parent  genomes.    


Utilizing accumulated patient data
Ultimately,  every  diagnostician  would  like  to  be  able  to  understand  clinical  relevance  of  a  chromosomal  anomaly  under  
scope  by  comparing  frequency  of  its  occurrence  in  patients  with  a  particular  disorder  vs.  healthy  patients.  This  can  be  


©2009  infoQuant,  Ltd                                               4                                                     Doc:  OCPEQS1  
 

  

done  if  array  CGH  data  for  large  cohorts  of  patients  have  been  accumulated  by  the  lab.  If  sufficient  number  of  patients  
with  the  disorder  were  tested,  such  data  can  be  used  to  build  an  aberration  frequency  profile  for  the  disease.  On  the  
other  hand,  you  can  use  data  from  healthy  patients  to  assess  frequency  of  normal  CNV  occurrence,  which  may  explain  
some  of  the  anomalies  initially  thought  to  be  related  to  the  disorder  under  study.  

CGH  Fusion  can  help  users  build  a  comprehensive  and  informative  aberration  frequency  profile  for  every  patient  group  
that  lab  has  accumulated  array  Copy  Number  data  for.  Publicly  available  datasets  can  also  be  used  for  such  purpose.    
You  can  easily  load  hundreds  or  thousands  of  samples  into  CGH  Fusion  and  perform  batch  copy  number  identification  on  
them.  Output  of  that  procedure  can  then  be  used  to  build  an  aberration  frequency  profile  illustrated  below.  




                                                                                                                                                  

Such  profile  clearly  indicates  regions  of  frequent  copy  number  anomalies  for  the  patient  cohort  under  study  and  
provides  a  quantitative  measure  of  aberration  frequency  in  the  cohort.  

By  re-­‐using  profiles  constructed  with  CGH  Fusion  in  oneClickCGH  during  a  routine  Cytogenetic  test,  one  can  
quantitatively  estimate  probability  of  an  aberration  region  contributing  to  a  particular  disorder.  




©2009  infoQuant,  Ltd                                                5                                                       Doc:  OCPEQS1  
 

  




                                                                                                                                               

Illustration  above  demonstrates  how  a  gain  and  a  loss  detected  in  a  sample  (upper  plot)  coincide  with  regions  of  high  
CNV  frequency  highlighted  by  green  and  red  peaks  of  aberration  frequency  profile  for  healthy  individuals  (lower  plot).  
Aberration  frequency  profile  was  constructed  using  data  from  HapMap  samples  extracted  using  Affymetrix  SNP  6.0  chip.  


Gene significance
Finally,  gene  annotations  for  a  chromosomal  region  of  interest  and  any  biological  information  associated  with  those  are  
probably  the  most  informative  pieces  of  the  puzzle  when  it  comes  to  interpreting  detected  aberrations.  Of  course,  one  
can  always  manually  review  sets  of  genes  from  suspect  regions  of  copy  number  change  and  skim  through  various  
publications  and  biological  information  associated  with  those  genes.  This  procedure  can  be  semi-­‐automated  with  
oneClickCGH  or  CGH  Fusion,  where  gene  annotations  are  conveniently  located  alongside  log-­‐ratio  plot.    

Picture  below  demonstrates  how  users  can  review  genes  within  a  region  of  interest  and  identify  conditions  genes  under  
scope  have  been  associated  with  in  available  publications.  This  example  illustrates  how  Angelman  syndrome  can  be  
added  to  the  list  of  conditions  a  copy  number  loss  on  chromosome  15  may  be  related  to.    




©2009  infoQuant,  Ltd                                              6                                                    Doc:  OCPEQS1  
 

  




                                                                                                                                                      

This  procedure  can  be  further  automated  by  short-­‐listing  genes  affected  by  copy  number  changes  along  genome  for  
current  sample.  By  a  click  of  a  button  users  can  display  a  table  listing  affected  genes  and  corresponding  significance  p-­‐
values  ordered  from  most  statistically  significant  to  least  statistically  significant.  The  table  also  lists  conditions  cited  in  
association  with  the  genes  and  corresponding  Ontology  terms.  Below  you  can  see  how  such  list  also  highlights  gene  
UBE3A  identified  in  the  previous  paragraph.  




©2009  infoQuant,  Ltd                                                   7                                                        Doc:  OCPEQS1  
 

  




                                                                                                                            


Conclusion
oneClickCGH  in  combination  with  CGH  Fusion  provide  a  powerful  suite  of  DNA  Copy  Number  analysis  tools  for  array  
users.  These  software  products  provide  the  new  level  of  in-­‐depth  array  data  interpretation  and  comprehensive  Copy  
Number  reporting  that  can  be  beneficial  for  an  individual  user  and  for  the  laboratory  workflow  as  a  whole.  It  is  a  truly  
universal  software  suite  that  is  capable  of  handling  array  data  of  any  resolution  obtained  with  any  hardware  platform:  
Affymetrix,  Agilent,  Illumina,  PerkinElmer,  Roche-­‐Nimblegen  and  more.  

  

                                        




©2009  infoQuant,  Ltd                                                  8                                                       Doc:  OCPEQS1  
 

  

  




©2009  infoQuant,  Ltd     9     Doc:  OCPEQS1  

Más contenido relacionado

La actualidad más candente

Development of a next-generation (NGS) assay for pediatric, childhood, and yo...
Development of a next-generation (NGS) assay for pediatric, childhood, and yo...Development of a next-generation (NGS) assay for pediatric, childhood, and yo...
Development of a next-generation (NGS) assay for pediatric, childhood, and yo...Thermo Fisher Scientific
 
Digging into thousands of variants to find disease genes in Mendelian and com...
Digging into thousands of variants to find disease genes in Mendelian and com...Digging into thousands of variants to find disease genes in Mendelian and com...
Digging into thousands of variants to find disease genes in Mendelian and com...Joaquin Dopazo
 
RNA capture sequencing enabled liquid biopsy screening
RNA capture sequencing enabled liquid biopsy screeningRNA capture sequencing enabled liquid biopsy screening
RNA capture sequencing enabled liquid biopsy screeningBiogazelle
 
From reads to pathways for efficient disease gene finding
From reads to pathways for efficient disease gene findingFrom reads to pathways for efficient disease gene finding
From reads to pathways for efficient disease gene findingJoaquin Dopazo
 
Bioinformatics and NGS for advancing in hearing loss research
Bioinformatics and NGS for advancing in hearing loss researchBioinformatics and NGS for advancing in hearing loss research
Bioinformatics and NGS for advancing in hearing loss researchJoaquin Dopazo
 
Intelligent Systems for Cancer Genomics (AIS305) - AWS re:Invent 2018
Intelligent Systems for Cancer Genomics (AIS305) - AWS re:Invent 2018Intelligent Systems for Cancer Genomics (AIS305) - AWS re:Invent 2018
Intelligent Systems for Cancer Genomics (AIS305) - AWS re:Invent 2018Amazon Web Services
 
The clinical application development and validation of cell free dna assays -...
The clinical application development and validation of cell free dna assays -...The clinical application development and validation of cell free dna assays -...
The clinical application development and validation of cell free dna assays -...Candy Smellie
 
Sequencing 60,000 Samples: An Innovative Large Cohort Study for Breast Cancer...
Sequencing 60,000 Samples: An Innovative Large Cohort Study for Breast Cancer...Sequencing 60,000 Samples: An Innovative Large Cohort Study for Breast Cancer...
Sequencing 60,000 Samples: An Innovative Large Cohort Study for Breast Cancer...QIAGEN
 
The Presence and Persistence of Resistant and Stem Cell-Like Tumor Cells as a...
The Presence and Persistence of Resistant and Stem Cell-Like Tumor Cells as a...The Presence and Persistence of Resistant and Stem Cell-Like Tumor Cells as a...
The Presence and Persistence of Resistant and Stem Cell-Like Tumor Cells as a...QIAGEN
 
Enabling CNV Studies from Single Cells Using Whole Genome Amplification and L...
Enabling CNV Studies from Single Cells Using Whole Genome Amplification and L...Enabling CNV Studies from Single Cells Using Whole Genome Amplification and L...
Enabling CNV Studies from Single Cells Using Whole Genome Amplification and L...QIAGEN
 
Aug2015 deanna church analytical validation
Aug2015 deanna church analytical validationAug2015 deanna church analytical validation
Aug2015 deanna church analytical validationGenomeInABottle
 
zandona14nipsA0
zandona14nipsA0zandona14nipsA0
zandona14nipsA0Pia Sen
 
A New Generation Of Mechanism-Based Biomarkers For The Clinic
A New Generation Of Mechanism-Based Biomarkers For The ClinicA New Generation Of Mechanism-Based Biomarkers For The Clinic
A New Generation Of Mechanism-Based Biomarkers For The ClinicJoaquin Dopazo
 
Translating Genomes | Personalizing Medicine
Translating Genomes | Personalizing MedicineTranslating Genomes | Personalizing Medicine
Translating Genomes | Personalizing MedicineCandy Smellie
 
Illumina-General-Overview-Q1-17
Illumina-General-Overview-Q1-17Illumina-General-Overview-Q1-17
Illumina-General-Overview-Q1-17Matthew Holguin
 
Viral Protein Structure Predictions - Consensus Strategy
Viral Protein Structure Predictions - Consensus StrategyViral Protein Structure Predictions - Consensus Strategy
Viral Protein Structure Predictions - Consensus StrategyKeiji Takamoto
 
CELL - FREE DNA TEST: ASPETTI EMERGENTI NELLA PRATICA QUOTIDIANA
CELL - FREE DNA TEST: ASPETTI EMERGENTI NELLA PRATICA QUOTIDIANACELL - FREE DNA TEST: ASPETTI EMERGENTI NELLA PRATICA QUOTIDIANA
CELL - FREE DNA TEST: ASPETTI EMERGENTI NELLA PRATICA QUOTIDIANARoberto Scarafia
 
How to transform genomic big data into valuable clinical information
How to transform genomic big data into valuable clinical informationHow to transform genomic big data into valuable clinical information
How to transform genomic big data into valuable clinical informationJoaquin Dopazo
 
Invicta eshre-poster-pregnancy rate after frozen blastocyst
Invicta eshre-poster-pregnancy rate after frozen blastocystInvicta eshre-poster-pregnancy rate after frozen blastocyst
Invicta eshre-poster-pregnancy rate after frozen blastocystINVICTA GENETICS
 

La actualidad más candente (20)

Development of a next-generation (NGS) assay for pediatric, childhood, and yo...
Development of a next-generation (NGS) assay for pediatric, childhood, and yo...Development of a next-generation (NGS) assay for pediatric, childhood, and yo...
Development of a next-generation (NGS) assay for pediatric, childhood, and yo...
 
Digging into thousands of variants to find disease genes in Mendelian and com...
Digging into thousands of variants to find disease genes in Mendelian and com...Digging into thousands of variants to find disease genes in Mendelian and com...
Digging into thousands of variants to find disease genes in Mendelian and com...
 
RNA capture sequencing enabled liquid biopsy screening
RNA capture sequencing enabled liquid biopsy screeningRNA capture sequencing enabled liquid biopsy screening
RNA capture sequencing enabled liquid biopsy screening
 
From reads to pathways for efficient disease gene finding
From reads to pathways for efficient disease gene findingFrom reads to pathways for efficient disease gene finding
From reads to pathways for efficient disease gene finding
 
Bioinformatics and NGS for advancing in hearing loss research
Bioinformatics and NGS for advancing in hearing loss researchBioinformatics and NGS for advancing in hearing loss research
Bioinformatics and NGS for advancing in hearing loss research
 
Intelligent Systems for Cancer Genomics (AIS305) - AWS re:Invent 2018
Intelligent Systems for Cancer Genomics (AIS305) - AWS re:Invent 2018Intelligent Systems for Cancer Genomics (AIS305) - AWS re:Invent 2018
Intelligent Systems for Cancer Genomics (AIS305) - AWS re:Invent 2018
 
The clinical application development and validation of cell free dna assays -...
The clinical application development and validation of cell free dna assays -...The clinical application development and validation of cell free dna assays -...
The clinical application development and validation of cell free dna assays -...
 
Sequencing 60,000 Samples: An Innovative Large Cohort Study for Breast Cancer...
Sequencing 60,000 Samples: An Innovative Large Cohort Study for Breast Cancer...Sequencing 60,000 Samples: An Innovative Large Cohort Study for Breast Cancer...
Sequencing 60,000 Samples: An Innovative Large Cohort Study for Breast Cancer...
 
The Presence and Persistence of Resistant and Stem Cell-Like Tumor Cells as a...
The Presence and Persistence of Resistant and Stem Cell-Like Tumor Cells as a...The Presence and Persistence of Resistant and Stem Cell-Like Tumor Cells as a...
The Presence and Persistence of Resistant and Stem Cell-Like Tumor Cells as a...
 
Enabling CNV Studies from Single Cells Using Whole Genome Amplification and L...
Enabling CNV Studies from Single Cells Using Whole Genome Amplification and L...Enabling CNV Studies from Single Cells Using Whole Genome Amplification and L...
Enabling CNV Studies from Single Cells Using Whole Genome Amplification and L...
 
Aug2015 deanna church analytical validation
Aug2015 deanna church analytical validationAug2015 deanna church analytical validation
Aug2015 deanna church analytical validation
 
zandona14nipsA0
zandona14nipsA0zandona14nipsA0
zandona14nipsA0
 
A New Generation Of Mechanism-Based Biomarkers For The Clinic
A New Generation Of Mechanism-Based Biomarkers For The ClinicA New Generation Of Mechanism-Based Biomarkers For The Clinic
A New Generation Of Mechanism-Based Biomarkers For The Clinic
 
Cancer Immunogenomics
Cancer ImmunogenomicsCancer Immunogenomics
Cancer Immunogenomics
 
Translating Genomes | Personalizing Medicine
Translating Genomes | Personalizing MedicineTranslating Genomes | Personalizing Medicine
Translating Genomes | Personalizing Medicine
 
Illumina-General-Overview-Q1-17
Illumina-General-Overview-Q1-17Illumina-General-Overview-Q1-17
Illumina-General-Overview-Q1-17
 
Viral Protein Structure Predictions - Consensus Strategy
Viral Protein Structure Predictions - Consensus StrategyViral Protein Structure Predictions - Consensus Strategy
Viral Protein Structure Predictions - Consensus Strategy
 
CELL - FREE DNA TEST: ASPETTI EMERGENTI NELLA PRATICA QUOTIDIANA
CELL - FREE DNA TEST: ASPETTI EMERGENTI NELLA PRATICA QUOTIDIANACELL - FREE DNA TEST: ASPETTI EMERGENTI NELLA PRATICA QUOTIDIANA
CELL - FREE DNA TEST: ASPETTI EMERGENTI NELLA PRATICA QUOTIDIANA
 
How to transform genomic big data into valuable clinical information
How to transform genomic big data into valuable clinical informationHow to transform genomic big data into valuable clinical information
How to transform genomic big data into valuable clinical information
 
Invicta eshre-poster-pregnancy rate after frozen blastocyst
Invicta eshre-poster-pregnancy rate after frozen blastocystInvicta eshre-poster-pregnancy rate after frozen blastocyst
Invicta eshre-poster-pregnancy rate after frozen blastocyst
 

Destacado

Ciclistica Santerno Fabbi Imola - 2013
Ciclistica Santerno Fabbi Imola - 2013Ciclistica Santerno Fabbi Imola - 2013
Ciclistica Santerno Fabbi Imola - 2013Luca Martelli
 
Large aCGH Datasets
Large aCGH DatasetsLarge aCGH Datasets
Large aCGH DatasetsJosephseki28
 
10 ingredients of successful Apps
10 ingredients of successful Apps10 ingredients of successful Apps
10 ingredients of successful AppsThe DO School
 

Destacado (7)

Ciclistica Santerno Fabbi Imola - 2013
Ciclistica Santerno Fabbi Imola - 2013Ciclistica Santerno Fabbi Imola - 2013
Ciclistica Santerno Fabbi Imola - 2013
 
10
1010
10
 
El BarçA
El BarçAEl BarçA
El BarçA
 
Rapportdesign basicpack
Rapportdesign basicpackRapportdesign basicpack
Rapportdesign basicpack
 
Large aCGH Datasets
Large aCGH DatasetsLarge aCGH Datasets
Large aCGH Datasets
 
El BarçA
El BarçAEl BarçA
El BarçA
 
10 ingredients of successful Apps
10 ingredients of successful Apps10 ingredients of successful Apps
10 ingredients of successful Apps
 

Similar a Overview Of Array Based Copy Number

CASSS Forum Poster - Enabling robist cloning method qualification in cell lin...
CASSS Forum Poster - Enabling robist cloning method qualification in cell lin...CASSS Forum Poster - Enabling robist cloning method qualification in cell lin...
CASSS Forum Poster - Enabling robist cloning method qualification in cell lin...IanTaylor50
 
Next Generation Sequencing methods
Next Generation Sequencing methods Next Generation Sequencing methods
Next Generation Sequencing methods Zohaib HUSSAIN
 
Developing a framework for for detection of low frequency somatic genetic alt...
Developing a framework for for detection of low frequency somatic genetic alt...Developing a framework for for detection of low frequency somatic genetic alt...
Developing a framework for for detection of low frequency somatic genetic alt...Ronak Shah
 
CNV and aneuploidy detection by Ion semiconductor sequencing
CNV and aneuploidy detection by Ion semiconductor sequencingCNV and aneuploidy detection by Ion semiconductor sequencing
CNV and aneuploidy detection by Ion semiconductor sequencingThermo Fisher Scientific
 
NGS Applications I (UEB-UAT Bioinformatics Course - Session 2.1.2 - VHIR, Bar...
NGS Applications I (UEB-UAT Bioinformatics Course - Session 2.1.2 - VHIR, Bar...NGS Applications I (UEB-UAT Bioinformatics Course - Session 2.1.2 - VHIR, Bar...
NGS Applications I (UEB-UAT Bioinformatics Course - Session 2.1.2 - VHIR, Bar...VHIR Vall d’Hebron Institut de Recerca
 
Detection of somatic mutations at 0.5% frequency from cfDNA and CTC DNA using...
Detection of somatic mutations at 0.5% frequency from cfDNA and CTC DNA using...Detection of somatic mutations at 0.5% frequency from cfDNA and CTC DNA using...
Detection of somatic mutations at 0.5% frequency from cfDNA and CTC DNA using...Thermo Fisher Scientific
 
John Boikov Personalised Medicine Essay, Mark - 95 out of 100
John Boikov Personalised Medicine Essay, Mark - 95 out of 100John Boikov Personalised Medicine Essay, Mark - 95 out of 100
John Boikov Personalised Medicine Essay, Mark - 95 out of 100John Boikov
 
Accelerating GWAS epistatic interaction analysis methods
Accelerating GWAS epistatic interaction analysis methodsAccelerating GWAS epistatic interaction analysis methods
Accelerating GWAS epistatic interaction analysis methodsPriscill Orue Esquivel
 
Towards Precision Medicine: Tute Genomics, a cloud-based application for anal...
Towards Precision Medicine: Tute Genomics, a cloud-based application for anal...Towards Precision Medicine: Tute Genomics, a cloud-based application for anal...
Towards Precision Medicine: Tute Genomics, a cloud-based application for anal...Reid Robison
 
EUSFLAT 2019: explainable neuro fuzzy recurrent neural network to predict col...
EUSFLAT 2019: explainable neuro fuzzy recurrent neural network to predict col...EUSFLAT 2019: explainable neuro fuzzy recurrent neural network to predict col...
EUSFLAT 2019: explainable neuro fuzzy recurrent neural network to predict col...Servio Fernando Lima Reina
 
X-Meeting Poster 2015 - Vallys A Coverage tool
X-Meeting Poster 2015 - Vallys A Coverage toolX-Meeting Poster 2015 - Vallys A Coverage tool
X-Meeting Poster 2015 - Vallys A Coverage toolGenomika Diagnósticos
 
Personalized Medicine Through Tumor Sequencing
Personalized Medicine Through Tumor SequencingPersonalized Medicine Through Tumor Sequencing
Personalized Medicine Through Tumor SequencingGolden Helix
 
Personalized Medicine through Tumor Sequencing
Personalized Medicine through Tumor SequencingPersonalized Medicine through Tumor Sequencing
Personalized Medicine through Tumor SequencingGolden Helix Inc
 
Automated Generation Of Synoptic Reports From Narrative Pathology Reports In ...
Automated Generation Of Synoptic Reports From Narrative Pathology Reports In ...Automated Generation Of Synoptic Reports From Narrative Pathology Reports In ...
Automated Generation Of Synoptic Reports From Narrative Pathology Reports In ...Kaela Johnson
 
GIAB for AMP GeT-RM Forum
GIAB for AMP GeT-RM ForumGIAB for AMP GeT-RM Forum
GIAB for AMP GeT-RM ForumGenomeInABottle
 

Similar a Overview Of Array Based Copy Number (20)

CASSS Forum Poster - Enabling robist cloning method qualification in cell lin...
CASSS Forum Poster - Enabling robist cloning method qualification in cell lin...CASSS Forum Poster - Enabling robist cloning method qualification in cell lin...
CASSS Forum Poster - Enabling robist cloning method qualification in cell lin...
 
Next Generation Sequencing methods
Next Generation Sequencing methods Next Generation Sequencing methods
Next Generation Sequencing methods
 
UNMSymposium2014
UNMSymposium2014UNMSymposium2014
UNMSymposium2014
 
Developing a framework for for detection of low frequency somatic genetic alt...
Developing a framework for for detection of low frequency somatic genetic alt...Developing a framework for for detection of low frequency somatic genetic alt...
Developing a framework for for detection of low frequency somatic genetic alt...
 
CNV and aneuploidy detection by Ion semiconductor sequencing
CNV and aneuploidy detection by Ion semiconductor sequencingCNV and aneuploidy detection by Ion semiconductor sequencing
CNV and aneuploidy detection by Ion semiconductor sequencing
 
AnoMalNet: outlier detection based malaria cell image classification method l...
AnoMalNet: outlier detection based malaria cell image classification method l...AnoMalNet: outlier detection based malaria cell image classification method l...
AnoMalNet: outlier detection based malaria cell image classification method l...
 
NGS Applications I (UEB-UAT Bioinformatics Course - Session 2.1.2 - VHIR, Bar...
NGS Applications I (UEB-UAT Bioinformatics Course - Session 2.1.2 - VHIR, Bar...NGS Applications I (UEB-UAT Bioinformatics Course - Session 2.1.2 - VHIR, Bar...
NGS Applications I (UEB-UAT Bioinformatics Course - Session 2.1.2 - VHIR, Bar...
 
poster3
poster3poster3
poster3
 
Detection of somatic mutations at 0.5% frequency from cfDNA and CTC DNA using...
Detection of somatic mutations at 0.5% frequency from cfDNA and CTC DNA using...Detection of somatic mutations at 0.5% frequency from cfDNA and CTC DNA using...
Detection of somatic mutations at 0.5% frequency from cfDNA and CTC DNA using...
 
John Boikov Personalised Medicine Essay, Mark - 95 out of 100
John Boikov Personalised Medicine Essay, Mark - 95 out of 100John Boikov Personalised Medicine Essay, Mark - 95 out of 100
John Boikov Personalised Medicine Essay, Mark - 95 out of 100
 
Accelerating GWAS epistatic interaction analysis methods
Accelerating GWAS epistatic interaction analysis methodsAccelerating GWAS epistatic interaction analysis methods
Accelerating GWAS epistatic interaction analysis methods
 
Towards Precision Medicine: Tute Genomics, a cloud-based application for anal...
Towards Precision Medicine: Tute Genomics, a cloud-based application for anal...Towards Precision Medicine: Tute Genomics, a cloud-based application for anal...
Towards Precision Medicine: Tute Genomics, a cloud-based application for anal...
 
EUSFLAT 2019: explainable neuro fuzzy recurrent neural network to predict col...
EUSFLAT 2019: explainable neuro fuzzy recurrent neural network to predict col...EUSFLAT 2019: explainable neuro fuzzy recurrent neural network to predict col...
EUSFLAT 2019: explainable neuro fuzzy recurrent neural network to predict col...
 
X-Meeting Poster 2015 - Vallys A Coverage tool
X-Meeting Poster 2015 - Vallys A Coverage toolX-Meeting Poster 2015 - Vallys A Coverage tool
X-Meeting Poster 2015 - Vallys A Coverage tool
 
A New Day for Myeloid Genomic Profiling - How NGS Advancements Are Providing ...
A New Day for Myeloid Genomic Profiling - How NGS Advancements Are Providing ...A New Day for Myeloid Genomic Profiling - How NGS Advancements Are Providing ...
A New Day for Myeloid Genomic Profiling - How NGS Advancements Are Providing ...
 
Personalized Medicine Through Tumor Sequencing
Personalized Medicine Through Tumor SequencingPersonalized Medicine Through Tumor Sequencing
Personalized Medicine Through Tumor Sequencing
 
Personalized Medicine through Tumor Sequencing
Personalized Medicine through Tumor SequencingPersonalized Medicine through Tumor Sequencing
Personalized Medicine through Tumor Sequencing
 
Vergadering20081209
Vergadering20081209Vergadering20081209
Vergadering20081209
 
Automated Generation Of Synoptic Reports From Narrative Pathology Reports In ...
Automated Generation Of Synoptic Reports From Narrative Pathology Reports In ...Automated Generation Of Synoptic Reports From Narrative Pathology Reports In ...
Automated Generation Of Synoptic Reports From Narrative Pathology Reports In ...
 
GIAB for AMP GeT-RM Forum
GIAB for AMP GeT-RM ForumGIAB for AMP GeT-RM Forum
GIAB for AMP GeT-RM Forum
 

Overview Of Array Based Copy Number

  • 1.                       Overview of array-based Copy Number analysis for Cytogenetics   Topics in Copy Number variation analysis       October  2009   ©2009  infoQuant,  Ltd   1   Doc:  OCPEQS1  
  • 2.     Contents   Overview  .................................................................................................................................................................................  2   Tools  ........................................................................................................................................................................................  2   An  array-­‐based  Cytogenetic  Test  ............................................................................................................................................  2   Using  parental  samples  ...........................................................................................................................................................  4   Utilizing  accumulated  patient  data  .........................................................................................................................................  4   Gene  significance  ....................................................................................................................................................................  6   Conclusion  ...............................................................................................................................................................................  8     Overview Array  CGH  technique  is  going  through  a  transition  from  being  purely  a  research  tool  to  being  used  in  clinical  Cytogenetic   tests  on  a  daily  basis.  Such  transition  calls  for  a  new  generation  of  analytical  solutions  capable  of  semi-­‐automated  and   reliable  copy  number  reporting.   Tools oneClickCGH®  is  a  unique  software  package  that  facilitates  automated  analysis  of  array  CGH  data  and  user-­‐friendly  copy   number  reporting  for  individual  samples.  Cytogenetic  labs  can  use  this  package  to  support  identification  of  clinically   relevant  copy  number  changes  and  to  build  robust  and  comprehensive  reports.  It  is  capable  of  analyzing  medium-­‐  and   high-­‐resolution  data  from  various  array  CGH  and  SNP  platforms.  Statistical  algorithms  used  in  this  software  ensure   reliability  of  aberration  detection,  which  assists  Cytogenetic  users  in  producing  their  final  report  documents.   CGH  Fusion®  is  a  leading  commercially  validated  package  used  for  analysis  of  array  CGH  data  across  multiple  samples.  It   is  capable  of  building  copy  number  profiles  for  large  sets  of  samples  within  a  specific  biological  context.  CGH  Fusion  can   facilitate  constriction  of  libraries  of  copy  number  profiles  characterizing  specific  disorders  or  cohorts  of  healthy  patients   in  a  simple  user-­‐friendly  manner.  It  can  also  provide  valuable  biological  insights  into  regions  of  frequent  copy  number   change  by  incorporating  various  gene  annotations  and  known  CNVs.   An array-based Cytogenetic Test Usually  analysis  of  test  data  extracted  with  array  CGH  or  SNP  array  starts  with  detection  of  suspected  regions  of  copy   number  changes.  Several  basic  operations  are  performed  on  raw  data  (depending  on  the  actual  array  platform  used):   background  subtraction,  normalization,  filtering  of  outlier  replicates  and  actual  detection  of  regions  of  abnormal  log-­‐ ©2009  infoQuant,  Ltd   2   Doc:  OCPEQS1  
  • 3.     ratio  values.  All  aforementioned  operations  can  be  performed  automatically  and  almost  no  manual  intervention  is   needed  at  that  stage.      However,  not  all  automatically  detected  chromosomal  aberration  regions  need  to  be  reported  as  relevant  to  the  test.   Some  of  them  can  be  simply  experimental  defects  and  some  come  from  regions  of  known  genetic  variance,  which  do  not   contribute  to  the  clinical  condition  under  study.     Therefore  a  manual  procedure  of  aberration  approval  and  reporting  is  needed.  Such  procedure  usually  is  centered   around  building  a  final  report  with  manually  approved  copy  number  changes  based  on  references  to  various  knowledge   databases  (public  or  internal).  Such  aberration  reporting  procedure  can  be  streamlined  with  oneClickCGH,  which  allows   creation  of  comprehensive  report  documents  in  various  formats  and  facilitates  references  to  publicly  available   databases  such  as  the  Data  Base  of  Genomic  Variants,  UCSC  Genome  Browser,  OMIM,  Gene  Ontology  database  etc.   First,  all  detected  copy  number  changes  need  to  be  reviewed  and  gene  and/or  known  CNV  annotations  can  be  used  to        After  all  detected  aberrations  have  been  approved  and  necessary  comments  have  been  added,  report  section  of   oneClickCGH  contains  only  relevant  regions  of  copy  number  change  that  can  be  saved  as  a  report  document     ©2009  infoQuant,  Ltd   3   Doc:  OCPEQS1  
  • 4.     Using parental samples ones.     ical.  However,     when  such  data  are  available,  CGH  Fusion can  provide  a  user-­‐friendly  environment  for  identification  and  reporting     User  can  simply  load  all  available  samples  into  CGH  Fusion,  analyze  them  simultaneously  and  review  them  side  by  side.   Plot  below  illustrates  this  operation.     It  is  easy  to  see  from  this  plot  that  two  out  of  three   mother s)  demonstrate  similar  aberrations,   which  also  coincide  with  a  region  of  known  CNVs  from  Toronto  DGV  highlighted  with  orange  at  the  top  of  the  plot.   a  known  CNV  inherited  from  one  of   parent  genomes.     Utilizing accumulated patient data Ultimately,  every  diagnostician  would  like  to  be  able  to  understand  clinical  relevance  of  a  chromosomal  anomaly  under   scope  by  comparing  frequency  of  its  occurrence  in  patients  with  a  particular  disorder  vs.  healthy  patients.  This  can  be   ©2009  infoQuant,  Ltd   4   Doc:  OCPEQS1  
  • 5.     done  if  array  CGH  data  for  large  cohorts  of  patients  have  been  accumulated  by  the  lab.  If  sufficient  number  of  patients   with  the  disorder  were  tested,  such  data  can  be  used  to  build  an  aberration  frequency  profile  for  the  disease.  On  the   other  hand,  you  can  use  data  from  healthy  patients  to  assess  frequency  of  normal  CNV  occurrence,  which  may  explain   some  of  the  anomalies  initially  thought  to  be  related  to  the  disorder  under  study.   CGH  Fusion  can  help  users  build  a  comprehensive  and  informative  aberration  frequency  profile  for  every  patient  group   that  lab  has  accumulated  array  Copy  Number  data  for.  Publicly  available  datasets  can  also  be  used  for  such  purpose.     You  can  easily  load  hundreds  or  thousands  of  samples  into  CGH  Fusion  and  perform  batch  copy  number  identification  on   them.  Output  of  that  procedure  can  then  be  used  to  build  an  aberration  frequency  profile  illustrated  below.     Such  profile  clearly  indicates  regions  of  frequent  copy  number  anomalies  for  the  patient  cohort  under  study  and   provides  a  quantitative  measure  of  aberration  frequency  in  the  cohort.   By  re-­‐using  profiles  constructed  with  CGH  Fusion  in  oneClickCGH  during  a  routine  Cytogenetic  test,  one  can   quantitatively  estimate  probability  of  an  aberration  region  contributing  to  a  particular  disorder.   ©2009  infoQuant,  Ltd   5   Doc:  OCPEQS1  
  • 6.       Illustration  above  demonstrates  how  a  gain  and  a  loss  detected  in  a  sample  (upper  plot)  coincide  with  regions  of  high   CNV  frequency  highlighted  by  green  and  red  peaks  of  aberration  frequency  profile  for  healthy  individuals  (lower  plot).   Aberration  frequency  profile  was  constructed  using  data  from  HapMap  samples  extracted  using  Affymetrix  SNP  6.0  chip.   Gene significance Finally,  gene  annotations  for  a  chromosomal  region  of  interest  and  any  biological  information  associated  with  those  are   probably  the  most  informative  pieces  of  the  puzzle  when  it  comes  to  interpreting  detected  aberrations.  Of  course,  one   can  always  manually  review  sets  of  genes  from  suspect  regions  of  copy  number  change  and  skim  through  various   publications  and  biological  information  associated  with  those  genes.  This  procedure  can  be  semi-­‐automated  with   oneClickCGH  or  CGH  Fusion,  where  gene  annotations  are  conveniently  located  alongside  log-­‐ratio  plot.     Picture  below  demonstrates  how  users  can  review  genes  within  a  region  of  interest  and  identify  conditions  genes  under   scope  have  been  associated  with  in  available  publications.  This  example  illustrates  how  Angelman  syndrome  can  be   added  to  the  list  of  conditions  a  copy  number  loss  on  chromosome  15  may  be  related  to.     ©2009  infoQuant,  Ltd   6   Doc:  OCPEQS1  
  • 7.       This  procedure  can  be  further  automated  by  short-­‐listing  genes  affected  by  copy  number  changes  along  genome  for   current  sample.  By  a  click  of  a  button  users  can  display  a  table  listing  affected  genes  and  corresponding  significance  p-­‐ values  ordered  from  most  statistically  significant  to  least  statistically  significant.  The  table  also  lists  conditions  cited  in   association  with  the  genes  and  corresponding  Ontology  terms.  Below  you  can  see  how  such  list  also  highlights  gene   UBE3A  identified  in  the  previous  paragraph.   ©2009  infoQuant,  Ltd   7   Doc:  OCPEQS1  
  • 8.       Conclusion oneClickCGH  in  combination  with  CGH  Fusion  provide  a  powerful  suite  of  DNA  Copy  Number  analysis  tools  for  array   users.  These  software  products  provide  the  new  level  of  in-­‐depth  array  data  interpretation  and  comprehensive  Copy   Number  reporting  that  can  be  beneficial  for  an  individual  user  and  for  the  laboratory  workflow  as  a  whole.  It  is  a  truly   universal  software  suite  that  is  capable  of  handling  array  data  of  any  resolution  obtained  with  any  hardware  platform:   Affymetrix,  Agilent,  Illumina,  PerkinElmer,  Roche-­‐Nimblegen  and  more.         ©2009  infoQuant,  Ltd   8   Doc:  OCPEQS1  
  • 9.       ©2009  infoQuant,  Ltd   9   Doc:  OCPEQS1